Evidence map›Paper›PMID 30755408›Full record

ArticleG3 (Bethesda, Md.)2019

Short-Homology-Mediated CRISPR/Cas9-Based Method for Genome Editing in Fission Yeast.

Aki Hayashi, Katsunori Tanaka

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Optimization of the CRISPR/Cas9 system usingmicroPublication biology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Advances in Accurate Microbial Genome-Editing CRISPR Technologies.Journal of microbiology and biotechnology · 2021
    Review
  14. Article
  15. Article
  16. Review
  17. Genome editing systems across yeast species.Current opinion in biotechnology · 2020
    Review
  18. Article
  19. Article
  20. Wellcome open research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aki HayashiDepartment of Bioscience, School of Science and Technology, Kwansei Gakuin University, Sanda, Hyogo, 669-1337, Japan akihayashi@kwansei.ac.jp katsunori@kwansei.ac.jp.ORCID 0000-0003-1953-1664
Katsunori TanakaDepartment of Bioscience, School of Science and Technology, Kwansei Gakuin University, Sanda, Hyogo, 669-1337, Japan akihayashi@kwansei.ac.jp katsunori@kwansei.ac.jp.ORCID 0000-0001-9692-0968
Kwansei Gakuin University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The CRISPR/Cas9 system enables the editing of genomes of numerous organisms through the induction of the double-strand breaks (DSB) at specific chromosomal targets. We improved the CRISPR/Cas9 system to ease the direct introduction of a point mutation or a tagging sequence into the chromosome by combining it with the noncanonical homology-directed DNA repair (HDR) based genome editing in fission yeast. We constructed convenient cloning vectors, which possessed a guide RNA (gRNA) expression module, or the humanized

Indexed as

Cloning, MolecularCRISPR-Cas SystemsGene EditingGenetic VectorsMutagenesis, Site-DirectedPoint MutationSchizosaccharomycesSchizosaccharomyces pombe ProteinsSchizosaccharomyces pombe ProteinsCRISPR/Cas9fission yeastknock-inpoint mutationshort-homology arm

Identifiers

PMID30755408
PMCPMC6469419
OpenAlexW2903728481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.